Characterization of Myeloproliferative Neoplasia With a Mutated IDH, SRSF2 or SF3B1 Allele (CARPEDIEM)
Clinical trial NCT06481345 · UNKNOWN
Trial details
- NCT number
- NCT06481345
- Sponsor
- University Hospital, Brest
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2024-06-25
- Primary completion
- 2026-05-31
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.